65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79724D0030
- Awardee
-
Immedica Pharma US Inc. UEI MS6UM2NBDW91
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 58% complete
- IDV ceiling
- $3,200,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 12, awarded a Federal Supply Schedule contract to Immedica Pharma US Inc. (doing business as Marinus Pharmaceuticals) under Schedule 65 IB on December 1, 2023, with a ceiling value of $3.2 million and performance through November 30, 2028.
Schedule 65 IB covers drugs, pharmaceuticals, and hematology-related products. This is a multiple-award schedule contract, meaning the VA places orders against the contractor's price list rather than conducting new competitions for each purchase. The contractor delivers pharmaceutical products to VA medical centers nationwide. The portfolio includes Marinus Pharmaceuticals' patented drug ganaxolone for the treatment of epilepsy, depression, and post-traumatic stress disorder, alongside a broader range of pharmaceutical and hematology products. The contract mechanism is designed to streamline procurement of specialized medications for veterans within the VA healthcare system through competitive pricing under the multiple-award vehicle structure.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79724D0030?
36F79724D0030 was awarded to Immedica Pharma US Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on December 1, 2023.
How much is contract 36F79724D0030 worth?
36F79724D0030's own ceiling is $3,200,000.
Who can order from contract 36F79724D0030?
36F79724D0030 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79724D0030 part of a contract vehicle?
Yes. 36F79724D0030 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79724D0030 competed?
The extent of competition for 36F79724D0030 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV